News Links
Press Releases and Product Information June 1, 2022
Abbott’s FreeStyle Libre® 3 Receives U.S. FDA Clearance – Features World’s Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor Vertex to Present New Data on VX-880 Clinical Trial at 82nd American Diabetes Association Annual Conference
Read MorePopular Press News for June 1, 2022
Diabetes Fast Facts Diabetes Burnout Can Lead to Bigger Health Problems Anchor Jason Guy shares daughter’s type 1 diabetes journey to bring awareness to skyrocketing insulin costs Nick Jonas reflects on his diabetes diagnosis at age 13: ‘I didn’t really know of anybody in the public eye who was living with it’ First-ever global coverage targets for diabetes adopted at the 75th World Health Assembly Health Beat: Close to a T1D Cure: New Insulin Regulating Implant Environmental pollutants may be the reason behind development of type 1 diabetes Scripps Whittier Diabetes Institute celebrates four decades in San Diego
Read MoreResearch News for June 1, 2022
Associations between persistent organic pollutants and type 1 diabetes in youth Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania (Full text HTML, PDF) Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes (Full text HTML, PDF) Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD Rhapsody TM VDJ CDR3 Assay Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) (Full text HTML, […]
Read MoreDaily Care News for June 1, 2022
Study: Gut Microbiota of People With T1D Varies Significantly From Healthy Controls Type 1 Diabetes and Broken Bones: What’s the Connection? The effect of COVID-19 on routine diabetes care and mortality in people with diabetes SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis Hypo-METRICS: Hypoglycaemia – MEasurement, ThResholds and ImpaCtS – A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health econom Up all night? Sleep Disruption in Parents of Young Children Newly […]
Read MoreCeliac News for May 25, 2022
Medications Can Exacerbate Symptoms of Celiac Disease Gluten could be at the root of your teen’s gastrointestinal problems. Here’s what to look for Mindful Table Owner talks Celiac Disease: “We want people to understand the severity” Anokion Announces Positive Data from Phase 1 ACeD Clinical Trial Evaluating KAN-101 as a Treatment for Celiac Disease Presented in a Plenary Session at DDW 2022 Psychosocial Support for Children With Celiac Disease Beyond Celiac Kicks off First-of-its-Kind Coalition to Accelerate Clinical Research in Celiac Disease Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease Analysis of […]
Read MorePress Releases and Product Information May 25, 2022
Sernova taps Evotec’s insulin-producing cells to fill its pouch implant for diabetes Novo Nordisk Education Foundation, GIMS launch CoE for Type 1 diabetes care How Glytec is advancing insulin management in the hospital
Read MorePopular Press News for May 25, 2022
‘If you miss it, they’re gone.’ Parents of children with Type I diabetes are always on alert Virtual diabetes conference will focus on research, care and breakthroughs Young people with diabetes to get psychological support in Jersey Type 1 diabetes study Medical Moment: Advancements in type 1 diabetes treatment Researchers working on cellular level to find cure for Type 1 diabetes Anchor Jason Guy shares daughter’s type 1 diabetes journey to bring awareness to skyrocketing insulin costs
Read MoreResearch News for May 25, 2022
No rejections for new islet transplantation method Altering the body’s immune system to treat type 1 diabetes Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial Functional Impact of Risk Gene Variants on the Autoimmune Responses in Type 1 Diabetes (Full text HTML, PDF) Accuracy of Real Time Continuous Glucose Monitoring during Different Liquid Solution Challenges in Healthy Adults: A Randomized Controlled Cross-Over Trial Deep Learning for Type 1 Diabetes Mellitus Diagnosis Using Infrared Quantum Cascade Laser Spectroscopy (Full text HTML, PDF) Partial Clinical Remission of Type […]
Read More